2019
DOI: 10.1080/1028415x.2019.1596371
|View full text |Cite
|
Sign up to set email alerts
|

Amyloid-beta induced paralysis is reduced by cholecalciferol through inhibition of the steroid-signaling pathway in an Alzheimer model ofCaenorhabditis elegans

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
5
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(5 citation statements)
references
References 27 publications
0
5
0
Order By: Relevance
“…Previous studies have shown that Aβ-induced paralysis in C. elegans is reduced by restricted cholesterol supply and inhibition of the steroid-signaling pathway. [6,7] Therefore, the downregulation of vit may alleviate Aβ-induced paralysis by inhibiting cholesterol metabolism. HSP-16.2 is a molecular chaperone that can interact with abnormally folded proteins and mediate their removal.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…Previous studies have shown that Aβ-induced paralysis in C. elegans is reduced by restricted cholesterol supply and inhibition of the steroid-signaling pathway. [6,7] Therefore, the downregulation of vit may alleviate Aβ-induced paralysis by inhibiting cholesterol metabolism. HSP-16.2 is a molecular chaperone that can interact with abnormally folded proteins and mediate their removal.…”
Section: Discussionmentioning
confidence: 99%
“…[ 9,14 ] The apolipoprotein that transports cholesterol in C. elegans is vitellogenin ( vit ), which is necessary for cholesterol intake in worms. [ 7 ]…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…The Aβ 1-42 peptides are derived from amyloid precursor protein (APP) through sequentially cleavage by β- and γ-secretases and self-polymerized into dimers or oligomers, which finally aggregate into Aβ plaques that cause oxidative damage and disrupt neuronal functions. 1 , 2 , 3 From the World Alzheimer Report in 2016, more than 46 million people are suffering from AD worldwide. The number of AD patients are estimated to increase and reach 74.7 million in 2030.…”
Section: Introductionmentioning
confidence: 99%